PYC Therapeutics Limited (ASX:PYC)
Australia · Delayed Price · Currency is AUD 1.285
+0.010 (0.78%)
Jun 4, 2026, 10:34 AM AEST
PYC Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, PYC Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.68. The average 1-year stock price forecast is 186.38% higher than the current stock price, while the lowest is $2.30 (+78.99%) and the highest is $5.00 (+289.11%).
Price Target: $3.68 (+186.38%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 15, 2026.
Analyst Ratings
The average analyst rating for PYC Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2.84 | Buy | Maintains | $2.84 | +121.01% | Apr 15, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $4.00 → $5.00 | Buy | Maintains | $4.00 → $5.00 | +289.11% | Mar 20, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $2.30 | Buy | Maintains | $2.30 | +78.99% | Mar 17, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.